Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;49(1):171-178.
doi: 10.1007/s11033-021-06855-3. Epub 2021 Oct 22.

Contribution of HLA class II genes, DRB4*01:01, DRB1*07:01, and DQB1*03:03:2 to clinical features of Vitiligo disease in Iranian population

Roya Ghaffarnia  1 , Zahra Saffarian  2 , Majid Shahbazi  3 , Mahdi Zamani  4
Affiliations

Contribution of HLA class II genes, DRB4*01:01, DRB1*07:01, and DQB1*03:03:2 to clinical features of Vitiligo disease in Iranian population

Roya Ghaffarnia et al. Mol Biol Rep. 2022 Jan.

Abstract

Background: Vitiligo is a multifactorial depigmentation condition, which is due to skin melanocyte destruction. Increased expression of HLA class II genes in patients with pre-lesions of Vitiligo suggests a crucial role for the participation of immune response in Vitiligo development. Recent studies progressively focused on HLA-DRB1 and DQB1 genes. In this study, we have evaluated the association and role of HLA-DRB4*01:01, -DRB1*07:01, and -DQB1*03:03:2 genes in different clinical subtypes of Vitiligo in the Iranian population.

Methods: First, Genomic DNA from peripheral blood of 125 unrelated Vitiligo patients and 100 unrelated healthy controls were extracted through the salting-out method. Then, HLA class II genotyping was performed using the sequence-specific primer PCR method. Finally, the clinical relevance of the testing for these genotypes was evaluated by applying the PcPPV (prevalence-corrected positive predictive value) formula.

Results: Our results indicated the positive associations of DRB4*01:01 and DRB1*07:01 allelic genes with early-onset Vitiligo (p = 0.024 and 0.022, respectively). DRB4*01:01 also showed strong protection against late-onset Vitiligo (p = 0.0016, RR = 0.360). Moreover, our data revealed that the DRB1*07:01 increases the susceptibility to Sporadic Vitiligo (p = 0.030, RR = 1.702). Furthermore, our findings proposed that elevated vulnerability of Vitiligo patients due to DRB4*01:01 and DRB1*07:01 alleles maybe is correlated with the presence of amino acid Arginine at position 71 at pocket 4 on the antigen-binding site of the HLA-DRB1 receptor.

Conclusion: Our findings on different subtypes of Vitiligo suggest that, despite a more apparent autoimmune involvement, a non-autoimmune nature for the etiology of Vitiligo should also be considered.

Keywords: HLA-DQB1; HLA-DRB1; HLA-DRB4; PCR-SSP; Vitiligo.

PubMed Disclaimer

References

    1. Rahman R, Hasija YJBD (2018) Exploring vitiligo susceptibility and management: a brief review. Biomed Dermatol 2(1):1–13 - DOI
    1. Wankowicz-Kalinska A et al (2004) Autoimmune aspects of depigmentation in vitiligo. J Invest Dermatol Sympos Proc 9:68–72 - DOI
    1. Roberts GHL (2019) Genetic architecture of vitiligo and vitiligo subtypes, The. University of Colorado at Denver, Anschutz Medical Campus, Aurora
    1. Ghosh SJ (2020) Chemical vitiligo: a subset of vitiligo. Indian J Dermatol 65(6):443 - DOI
    1. Roberts GH et al (2020) The genetic architecture of vitiligo. Pigment Cell Melanoma Res 33(1):8–15 - DOI

LinkOut - more resources